Re: AIDS R01's Niejako, Joyce 21 Dec 2006 12:52 EST
Thanks for the confirmation. Thanks! Joyce Joyce Niejako Grants & Contracts Specialist Office for Sponsored Programs University of Connecticut Phone: 860-486-8798 Fax: 860-486-3726 >-----Original Message----- >From: Research Administration List >[mailto:xxxxxx@hrinet.org] On Behalf Of Wilson, Thomas >Sent: Thursday, December 21, 2006 12:47 PM >To: xxxxxx@hrinet.org >Subject: Re: [RESADM-L] AIDS R01's > >They will not become electronic until after the R01 mechanism goes >electronic on February 5, 2007. After that point all R01 submissions >will be accepted only through Grants.gov on the 424R&R. > >Tom Wilson > >Thomas E. Wilson, MBA >Director, Sponsored Projects >City of Hope National Medical Center > and Beckman Research Institute >1500 East Duarte Road >Duarte, CA 91010-3000 > >Tel: 626-301-8438 >Fax: 626-301-8843 > > >-----Original Message----- >From: Research Administration List [mailto:xxxxxx@hrinet.org] On >Behalf Of Niejako, Joyce >Sent: Thursday, December 21, 2006 9:34 AM >To: xxxxxx@hrinet.org >Subject: [RESADM-L] AIDS R01's > >Please assure me that AIDS R01's are still paper for the Jan. 2 >submission? > >Thanks! Joyce > >Joyce Niejako >Grants & Contracts Specialist >Office for Sponsored Programs >University of Connecticut >Phone: 860-486-8798 Fax: 860-486-3726 > > >====================================================================== > Instructions on how to use the RESADM-L Mailing List, including >subscription information and a web-searchable archive, are available >via our web site at http://www.hrinet.org (click on "Listserv Lists") >====================================================================== > > >"EMF <COH.org>" made the following annotations. >--------------------------------------------------------------- >--------------- >SECURITY/CONFIDENTIALITY WARNING: This message and any >attachments are intended solely for the individual or entity >to which they are addressed. This communication may contain >information that is privileged, confidential, or exempt from >disclosure under applicable law (e.g., personal health >information, research data, financial information). Because >this e-mail has been sent without encryption, individuals >other than the intended recipient may be able to view the >information, forward it to others or tamper with the >information without the knowledge or consent of the sender. If >you are not the intended recipient, or the employee or person >responsible for delivering the message to the intended >recipient, any dissemination, distribution or copying of the >communication is strictly prohibited. If you received the >communication in error, please notify the sender immediately >by replying to this message and deleting the message and any >accompanying files from your system. If, due t! > o the security risks, you do not wish to receive further >communications via e-mail, please reply to this message and >inform the sender that you do not wish to receive further >e-mail from the sender. >=============================================================== >=============== > > >====================================================================== > Instructions on how to use the RESADM-L Mailing List, including > subscription information and a web-searchable archive, are available > via our web site at http://www.hrinet.org (click on "Listserv Lists") >====================================================================== > > ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================